XML 60 R47.htm IDEA: XBRL DOCUMENT
v3.3.1.900

ACQUISITIONS AND PRO FORMA RESULTS (Narrative) (Details) |  |  |  |  |  |  |  | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 15, 2015 USD ($) | Oct. 02, 2015 USD ($) | Jul. 17, 2015 USD ($) acquisition | Dec. 05, 2014 USD ($) | Oct. 27, 2014 USD ($) | Jan. 15, 2014 USD ($) | Jan. 24, 2013 USD ($) | Dec. 31, 2015 USD ($) | Jun. 30, 2015 USD ($) | Sep. 30, 2014 USD ($) intangible_asset | Jun. 30, 2014 USD ($) | Sep. 30, 2015 USD ($) | Dec. 31, 2015 USD ($) | Dec. 31, 2014 USD ($) | Dec. 31, 2013 USD ($)
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business combination, bargain purchase, gain recognized, amount |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,111,000 | $ 0 | $ 0
Number of businesses acquired | acquisition |  |  | 2 |  |  |  |  |  |  |  |  |  |  |  |
Payments to acquire businesses, net of cash acquired |  |  |  |  |  |  |  |  |  |  |  |  | 328,888,000 | 320,921,000 | $ 2,980,000
Business combination, contingent consideration, liability |  |  |  |  |  |  |  | $ 21,831,000 |  |  |  |  | 21,831,000 | 22,008,000 |
Tekmed |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration transferred | $ 14,200,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue since acquisition date |  |  |  |  |  |  |  |  |  |  |  |  | 300,000 |  |
Net assets acquired |  |  |  |  |  |  |  | 14,152,000 |  |  |  |  | 14,152,000 |  |
Salto and Futura |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue since acquisition date |  |  |  |  |  |  |  |  |  |  |  |  | 3,600,000 |  |
Payments to acquire business |  | $ 6,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Net assets acquired |  |  |  |  |  |  |  | 7,111,000 |  |  |  |  | 7,111,000 |  |
TEI |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration transferred |  |  | $ 312,400,000 |  |  |  |  |  |  |  |  |  |  |  |
Revenue since acquisition date |  |  |  |  |  |  |  |  |  |  |  |  | 27,000,000 |  |
Payments to acquire businesses, net of cash acquired |  |  | 312,400,000 |  |  |  |  |  |  |  |  |  |  |  |
Business combination, recognized identifiable assets acquired and liabilities assumed, cash and equivalents |  |  | 1,241,000 |  |  |  |  |  |  |  |  |  |  |  |
Business combination, contingent consideration, asset |  |  | 400,000 |  |  |  |  |  |  |  |  |  |  |  |
Business combination, contingent consideration, asset, revenue threshold to realize asset |  |  | $ 6,000,000 |  |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  | 11.00% |  |  |  |  |  |  |  |  |  |  |  |
TEI | Deferred Tax Liability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill adjustments |  |  |  |  |  |  |  | 1,100,000 |  |  |  |  |  |  |
TEI Biosciences Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration transferred |  |  | $ 210,400,000 |  |  |  |  |  |  |  |  |  |  |  |
TEI Medical Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration transferred |  |  | $ 102,000,000 |  |  |  |  |  |  |  |  |  |  |  |
Metasurg |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration transferred |  |  |  | $ 27,200,000 |  |  |  |  |  |  |  |  |  |  |
Payments to acquire business |  |  |  | 26,500,000 |  |  |  |  |  |  |  |  |  |  |
Business combination, contingent consideration, liability |  |  |  | 700,000 |  |  |  | 0 |  |  |  |  | 0 |  |
Contingent consideration arrangements, maximum payout |  |  |  | $ 38,500,000 |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  | 19.90% |  |  |  |  |  |  |  |  |  |  |
Adjustment on consideration transferred |  |  |  |  |  |  |  |  | $ 400,000 |  |  |  |  |  |
Net assets acquired |  |  |  |  |  |  |  | 27,558,000 |  |  |  |  | 27,558,000 |  |
Goodwill adjustments |  |  |  |  |  |  |  |  |  |  |  |  | 263,000 |  |
Medtronic MicroFrance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payments to acquire business |  |  |  |  | $ 61,600,000 |  |  |  |  |  |  |  |  |  |
Business combination, recognized identifiable assets acquired and liabilities assumed, cash and equivalents |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,195,000 |
Adjustment on consideration transferred |  |  |  |  |  |  |  |  |  |  |  | $ 1,500,000 |  |  |
Net assets acquired |  |  |  |  |  |  |  |  |  |  |  |  |  | 60,067,000 |
Goodwill adjustments |  |  |  |  |  |  |  |  |  |  |  |  | (1,069,000) |  |
Confluent Surgical, Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue since acquisition date |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 69,000,000 |
Business combination, contingent consideration, liability |  |  |  |  |  | $ 20,900,000 |  |  |  |  |  |  |  |  |
Contingent consideration arrangements, maximum payout |  |  |  |  |  | $ 30,000,000 |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  | 2.20% |  |  |  |  |  |  |  |  |
Net assets acquired |  |  |  |  |  | $ 255,900,000 |  | 255,895,000 |  |  |  |  | 255,895,000 |  |
Payment for business interest |  |  |  |  |  | 231,000,000 |  |  |  |  |  |  |  |  |
Payments for transitional supply agreement |  |  |  |  |  | $ 4,000,000 |  |  |  |  |  |  |  |  |
Arrangement extension period |  |  |  |  |  | 2 years |  |  |  |  |  |  |  |  |
Required number of days for extension |  |  |  |  |  | 180 days |  |  |  |  |  |  |  |  |
Period of contingent consideration arrangement |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |
Period of transitional supply price increases |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |
Number of assets impaired | intangible_asset |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |
Impairment of finite-lived assets |  |  |  |  |  |  |  |  |  | $ 600,000 |  |  | 600,000 |  |
Probability of event |  |  |  |  |  | 95.00% |  |  |  |  |  |  |  |  |
Incremental increase in liability |  |  |  |  |  | $ 300,000 |  |  |  |  |  |  |  |  |
Incremental decrease in liability |  |  |  |  |  | 400,000 |  |  |  |  |  |  |  |  |
Confluent Surgical, Inc. | Deferred Tax Liability |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill adjustments |  |  |  |  |  |  |  |  |  |  | $ 12,400,000 |  |  |  |
Confluent Surgical, Inc. | Cash Consideration One |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration arrangements, maximum payout |  |  |  |  |  | 25,000,000 |  |  |  |  |  |  |  |  |
Confluent Surgical, Inc. | Cash Consideration Two |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contingent consideration arrangements, maximum payout |  |  |  |  |  | $ 5,000,000 |  |  |  |  |  |  |  |  |
Tarsus Medical, Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payments to acquire business |  |  |  |  |  |  | $ 4,700,000 |  |  |  |  |  |  |  |
Payments to acquire businesses, net of cash acquired |  |  |  |  |  |  | 3,100,000 |  |  |  |  |  |  |  |
Business combination, recognized identifiable assets acquired and liabilities assumed, cash and equivalents |  |  |  |  |  |  | 85,000 |  |  |  |  |  |  |  |
Business combination, contingent consideration, liability |  |  |  |  |  |  | 1,600,000 | 0 |  |  |  |  | 0 |  |
Contingent consideration arrangements, maximum payout |  |  |  |  |  |  | 11,500,000.0 |  |  |  |  |  |  |  |
Adjustment on consideration transferred |  |  |  |  |  |  | 200,000 |  |  |  |  |  |  |  |
Net assets acquired |  |  |  |  |  |  | 4,665,000 |  |  |  |  |  |  |  |
Contingent consideration, low estimate |  |  |  |  |  |  | $ 1,500,000.0 |  |  |  |  |  |  |  |
Tarsus Medical, Inc. | Cash Consideration One |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  | 4.30% |  |  |  |  |  |  |  |
Tarsus Medical, Inc. | Cash Consideration Two |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  | 16.50% |  |  |  |  |  |  |  |
Other Income | Salto and Futura |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business combination, bargain purchase, gain recognized, amount |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,100,000 |  |
Selling, general and administrative | Metasurg |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Business combination, contingent consideration arrangements, change in amount of contingent consideration, liability |  |  |  |  |  |  |  | $ 700,000 |  |  |  |  |  |  |

X
- Definition Period of extension able to be exercised as part of the contingent consideration arrangement + References No definition available. + Details
Name: | iart_BusinessCombinationContingentConsiderationArrangementsArrangementExtensionPeriod
Namespace Prefix: | iart_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Contingent Consideration Arrangements, Period of Contingent Consideration Arrangement + References No definition available. + Details
Name: | iart_BusinessCombinationContingentConsiderationArrangementsPeriodofContingentConsiderationArrangement
Namespace Prefix: | iart_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Incremental Decrease in Liability + References No definition available. + Details
Name: | iart_BusinessCombinationContingentConsiderationArrangementsRangeofOutcomesValueIncrementalDecreaseinLiability
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Incremental Increase in Liability + References No definition available. + Details
Name: | iart_BusinessCombinationContingentConsiderationArrangementsRangeofOutcomesValueIncrementalIncreaseinLiability
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Business Combination, Contingent Consideration Arrangements, Required Number of Days for Extension + References No definition available. + Details
Name: | iart_BusinessCombinationContingentConsiderationArrangementsRequiredNumberofDaysforExtension
Namespace Prefix: | iart_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination, Contingent Consideration, Asset, Revenue Threshold To Realize Asset + References No definition available. + Details
Name: | iart_BusinessCombinationContingentConsiderationAssetRevenueThresholdToRealizeAsset
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Period during which the price of the agreement increases based upon the contingent consideration arrangement + References No definition available. + Details
Name: | iart_BusinessCombinationsContingentConsiderationArrangementPeriodofTransitionalSupplyPriceIncreases
Namespace Prefix: | iart_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair Value Input, Probability of Event + References No definition available. + Details
Name: | iart_FairValueInputProbabilityofEvent
Namespace Prefix: | iart_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Impairment of Intangible Assets, Finite-lived, Number of Assets Impaired + References No definition available. + Details
Name: | iart_ImpairmentofIntangibleAssetsFinitelivedNumberofAssetsImpaired
Namespace Prefix: | iart_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Payments to Acquire Businesses, Payment for Business Interest + References No definition available. + Details
Name: | iart_PaymentstoAcquireBusinessesPaymentforBusinessInterest
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payments to Acquire Businesses, Payments for Transitional Supply Agreement + References No definition available. + Details
Name: | iart_PaymentstoAcquireBusinessesPaymentsforTransitionalSupplyAgreement
Namespace Prefix: | iart_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition In a business combination in which the amount of net identifiable assets acquired and liabilities assumed exceeds the aggregate consideration transferred or to be transferred (as defined), this element represents the amount of gain recognized by the entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6393-128476 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6527-128477 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (f)(1) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6571-128477 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6387-128476 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6396-128476 + Details
Name: | us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 4 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of asset recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph b -URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationAsset
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph b -URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 6 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463 + Details
Name: | us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueInputsDiscountRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e961-128460 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillPurchaseAccountingAdjustments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275 + Details
Name: | us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of businesses acquired by the entity during the period. + References No definition available. + Details
Name: | us-gaap_NumberOfBusinessesAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_TekmedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_SaltoandFuturaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_TEIMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=iart_DeferredTaxLiabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_TEIBiosciencesInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_TEIMedicalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_MetasurgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_MedtronicMicroFranceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_ConfluentSurgicalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=iart_CashConsiderationOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=iart_CashConsiderationTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_TarsusMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=iart_SellingGeneralAndAdministrativeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |